Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Health advisor facilitated mouth care regime for patients with head and neck cancers undergoing intensity-modulated radiotherapy

Health advisor facilitated mouth care regime for patients with head and neck cancers undergoing... AbstractAimTo develop a regime of care for patients with head and neck cancers undergoing intensity-modulated radiotherapy (IMRT), with the support of a health advisor (HA) and temporary access to the mouth care product Caphosol™.Materials and methodsA HA was temporarily employed to assess, monitor and refer patients as appropriate and ensure patients received and utilised supplies of Caphosol™. A retrospective audit was undertaken to provide a gap analysis of current service. The data were used to develop a pro forma for documenting assessments and monitoring lifestyle factors for IMRT patients. Assessments referrals and compliance, plus hospital admissions owing to treatment-related issues, were documented during the baseline audit and the temporary HA service and provision of Caphosol™.ResultsThe presence of a HA facilitated 100% compliance with appropriate assessments, referrals and adherence to treatment. The data suggests that the additional provision of Caphosol™ may have reduced levels of mucositis and associated pain.ConclusionIt is recommended that a HA role be established within radiotherapy departments to facilitate lifestyle assessments, referrals and compliance with positive behaviour changes (e.g., stopping smoking). The use of Caphosol™ as a routine part of mouth care regime for IMRT patients also warrants further investigation. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Radiotherapy in Practice Cambridge University Press

Health advisor facilitated mouth care regime for patients with head and neck cancers undergoing intensity-modulated radiotherapy

Journal of Radiotherapy in Practice , Volume 14 (4): 9 – Jul 30, 2015
Download PDF
9 pages

Loading next page...
 
/lp/cambridge-university-press/health-advisor-facilitated-mouth-care-regime-for-patients-with-head-fadN32IHNi

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Cambridge University Press
Copyright
© Cambridge University Press 2015 
ISSN
1467-1131
eISSN
1460-3969
DOI
10.1017/S1460396915000369
Publisher site
See Article on Publisher Site

Abstract

AbstractAimTo develop a regime of care for patients with head and neck cancers undergoing intensity-modulated radiotherapy (IMRT), with the support of a health advisor (HA) and temporary access to the mouth care product Caphosol™.Materials and methodsA HA was temporarily employed to assess, monitor and refer patients as appropriate and ensure patients received and utilised supplies of Caphosol™. A retrospective audit was undertaken to provide a gap analysis of current service. The data were used to develop a pro forma for documenting assessments and monitoring lifestyle factors for IMRT patients. Assessments referrals and compliance, plus hospital admissions owing to treatment-related issues, were documented during the baseline audit and the temporary HA service and provision of Caphosol™.ResultsThe presence of a HA facilitated 100% compliance with appropriate assessments, referrals and adherence to treatment. The data suggests that the additional provision of Caphosol™ may have reduced levels of mucositis and associated pain.ConclusionIt is recommended that a HA role be established within radiotherapy departments to facilitate lifestyle assessments, referrals and compliance with positive behaviour changes (e.g., stopping smoking). The use of Caphosol™ as a routine part of mouth care regime for IMRT patients also warrants further investigation.

Journal

Journal of Radiotherapy in Practice – Cambridge University Press

Published: Jul 30, 2015

Keywords: head and neck; intensity-modulated radiotherapy; mouth care; nasal; oral

References

  • Intensity‐modulated radiation therapy in head and neck cancers: an update
  • Oral and dental management for head and neck cancer patients treated by chemotherapy and radiotherapy
  • A retrospective match controlled study of supersaturated calcium phosphate oral rinse vs. supportive care for radiation induced oral mucositis
  • Efficacy of a supersaturated calcium phosphate oral rinse for the prevention and treatment of oral mucositis in patients receiving high‐dose cancer therapy: a review of current data
  • Strategies for managing radiation-induced mucositis in head and neck cancer
  • Psychological factors and patient delays in patients with head and neck cancer
  • Smoking cessation among patients with head and neck cancer: cancer as a ‘teachable moment’
  • Psychologic distress and head and neck cancer: part 1—review of the literature
  • A tailored smoking, alcohol and depression intervention for head and neck cancer patients
  • Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium
  • Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer
  • Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma – a prospective study
  • The hospital anxiety and depression scale
  • The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking
  • Systematic review of basic oral care for the management of oral mucositis in cancer patients